An R&D Blueprint for Action to Prevent Epidemics: Funding & Coordination Models for Preparedness and Response

An essential condition for better R&D preparedness and response is the availability of funding. However, there is currently insufficient funding to cover the required R&D to address pathogens included in the Blueprint. New and innovative funding models are needed to more sustainably fund R&D for emergency response and preparedness. In previous years, many different innovative funding models have been discussed for R&D for neglected diseases and other poverty-related illnesses.

This report presents options on how to ensure that the required research activities are financed and take place in the most efficient way, involving all necessary stakeholders. The Consultation on Financing for R&D preparedness and response to public health emergencies due to highly infectious pathogens in Oslo highlighted the need to start quickly, with the focused objective of defining target product profiles for medical products to address a specific set of the identified pathogens. One of the Consultation’s recommendations was to seek mechanisms to ensure sustainable financing, starting by engaging those stakeholders who are ready to move. Discussions in different fora such as the G7 and the G20 and the UN General Assembly are ongoing and will hopefully result in the creation of a funding mechanism.